Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

General Dynamics is a strong buy. With a $90B backlog, defense growth, and expanding aerospace segments, see more on GD stock ...

Five companies eligible for inclusion in our IPO stats went public this week, joined by four SPACs and a nano-cap.

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

Learn more about the potential of iShares MSCI Chile ETF (ECH) amid election-driven shifts. Analyze low valuations, economic ...

IBM's hybrid cloud expansion, watsonx AI, and improving margins signal a 19% upside. Read here for an investment analysis of ...

Lavras Gold Corp recently discovered gold in Brazil. Read more on LGC:CA stock's funding, exploration efforts and stock ...

Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

Super Micro Computer is rated a Buy for its strong AI-driven revenue growth despite risks like governance and volatility.

Daniel Ghali, Director, Commodities Strategy at TD Securities, breaks down what it could mean for oil, gold and the wider ...

JPMorgan on Friday updated its U.S. economic outlook and now sees the country slipping into a recession in 2025. Read more ...

Stock prices and the dollar fell due to punitive tariffs. See why a policy reversal is inevitable, and why markets will ...